logo

For the Inventor, By the Inventor

Carmel, IN, United States of America

Jian-Ting Zhang

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Indiana University. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian-Ting Zhang. Retrieved from https://idiyas.com/inventor/jian-ting-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 1.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal5 out of 809 
 
Indiana University
 patents

Years Active: 2013-2024

Loading Chart...
5 patents (USPTO):Explore Patents
1. 12115158 - Survivin-targeting anti-tumor agents and uses thereof (2024-10-15),
2. 11491147 - Combination drug therapy reduces PARP-1 related DNA repair and increases the efficacy of genotoxic agents (2022-11-08),
3. 10517871 - Survivin-targeting anti-tumor agents and uses thereof (2019-12-31),
4. 9382204 - Inhibitors targeting the DNA-binding domain of human STAT3 for treatment of metastatic cancers (2016-07-05),
5. 8455252 - Materials and methods for sensitizing multidrug resistant cells (2013-06-04),

Title: Innovations in Cancer Treatment by Jian-Ting Zhang

Introduction

Jian-Ting Zhang is a prominent inventor based in Carmel, Indiana, known for his significant contributions to cancer treatment through innovative pharmaceutical compositions. With a total of five patents to his name, Zhang's work focuses on targeting specific proteins involved in cancer progression.

Latest Patents

Zhang's latest patents include groundbreaking methods for treating various cancers by administering compounds that target the dimeric protein survivin. These methods not only disclose pharmaceutical compositions containing such compounds but also outline general techniques for identifying anti-cancer compounds that target oncogenic dimeric proteins. Another notable patent involves combination drug therapy that reduces PARP-1 related DNA repair, thereby increasing the efficacy of genotoxic agents. This patent details methods for treating cancer by providing patients with therapeutic regimes that include agents reducing the activity of DNA damage/repair pathways.

Career Highlights

Zhang is affiliated with Indiana University, where he continues to advance research in cancer therapies. His innovative approaches have the potential to significantly improve treatment outcomes for patients diagnosed with various forms of cancer.

Collaborations

Zhang collaborates with esteemed colleagues such as Jing-Yuan Liu and Mingji Dai, contributing to a dynamic research environment focused on cancer treatment advancements.

Conclusion

Jian-Ting Zhang's innovative work in cancer treatment exemplifies the impact of targeted therapies in modern medicine. His patents reflect a commitment to improving patient outcomes through scientific research and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…